Although SETDB1 has been suggested to have an oncogenic impact in lung cancer based on transcription level or expression data [21,25], our results suggest that at least some of the identified SETDB1 somatic mutations are probably loss of function mutations. Here, SETDB1 is linked to lung cancer.